Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.
Cancer. 2006 May 15;106(10):2241-6. doi: 10.1002/cncr.21874.
Cancer. 2006.
PMID: 16598762
Free article.
Clinical Trial.
A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma.
Hoff PM, Wolff RA, Bogaard K, Waldrum S, Abbruzzese JL.
Hoff PM, et al.
Jpn J Clin Oncol. 2006 Feb;36(2):100-3. doi: 10.1093/jjco/hyi229. Epub 2006 Jan 31.
Jpn J Clin Oncol. 2006.
PMID: 16449240
Clinical Trial.
Item in Clipboard
Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors.
Hong DS, Abbruzzese JL, Bogaard K, Lassere Y, Fukushima M, Mita A, Kuwata K, Hoff PM.
Hong DS, et al.
Cancer. 2006 Sep 15;107(6):1383-90. doi: 10.1002/cncr.22125.
Cancer. 2006.
PMID: 16902987
Free article.
Clinical Trial.
Item in Clipboard
Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer.
Hoff PM, Saad ED, Pazdur R, Wolff R, Lassere Y, Bogaard KR, Abbruzzese JL.
Hoff PM, et al. Among authors: bogaard kr.
Invest New Drugs. 2004 Aug;22(3):307-13. doi: 10.1023/B:DRUG.0000026257.31142.41.
Invest New Drugs. 2004.
PMID: 15122078
Clinical Trial.
Item in Clipboard
Cite
Cite